HighMark Wealth Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.12M Buy
237,285
+1,500
+0.6% +$19.7K 1.52% 13
2025
Q1
$3.39M Buy
235,785
+69,650
+42% +$1M 2% 9
2024
Q4
$2.78M Sell
166,135
-1,000
-0.6% -$16.8K 1.6% 10
2024
Q3
$2.67M Buy
167,135
+74,135
+80% +$1.19M 1.46% 11
2024
Q2
$840K Buy
+93,000
New +$840K 0.51% 27